How Long Does 1mg Wegovy Stay in Your System?

Semaglutide's half-life is approximately seven days at every dose, including 1mg — elimination is slow and consistent regardless of the weekly dose level.
Full clearance from the body takes roughly five half-lives, or around five weeks after the last injection at any stage of the titration schedule.
The 1mg strength sits in the middle of the titration ladder: most people reach it after progressing from 0.25mg and 0.5mg, before moving to higher maintenance doses.
How quickly you feel effects ease off after stopping will differ from the pharmacokinetic timeline, appetite often returns before the medicine has fully cleared.

At the 1mg dose, semaglutide has a half-life of roughly seven days, meaning it takes around five weeks for the medicine to clear your system entirely after your last injection. That extended half-life is by design: it keeps semaglutide active for a full week between doses, which is why Wegovy is injected once weekly. Understanding how long it lingers matters most when you are thinking about a missed dose, a planned break, switching treatments, or planning a pregnancy. These are clinical decisions, and a prescriber needs to weigh them with you — but the pharmacology itself is worth understanding. Wegovy is a prescription-only semaglutide injection for weight management in adults, and clinical assessment determines whether it is suitable for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the pharmacology of 1mg semaglutide means for your practical decisions

The half-life is the same at 1mg as it is at every other dose, here is what that tells you

Semaglutide's half-life of around seven days is a fixed property of the molecule, not something that changes as the dose goes up or down. Whether you are at the 0.25mg starting point or the 2.4mg maintenance dose, each milligram you inject follows the same elimination curve. At the 1mg level specifically, roughly half of the active semaglutide in your body is cleared every seven days, and five clearance cycles (about five weeks) are generally required before it falls to negligible levels.

One misconception worth letting go quietly: some people assume that a lower dose clears faster because there is less of it. That is not how half-lives work. The proportion cleared per unit of time stays constant; the absolute amount diminishes logarithmically. So at 1mg, as at the 0.5mg stage, the timeline to full clearance is broadly the same five-week window.

The NHS medicines page for semaglutide confirms this pharmacokinetic profile, and it is also detailed in the NHS patient information for semaglutide. Clearance timelines can shift slightly with kidney function, body composition, and individual metabolism, which is why any decision based on this timeline should involve your prescriber rather than a calculation alone.

Why the decision you are facing right now shapes what this information means

The pharmacokinetic timeline only becomes practically meaningful once you know what decision you are making. The answer looks different depending on the situation.

If you have missed a dose at the 1mg stage, the long half-life actually works in your favour: because semaglutide persists, a single missed weekly injection is unlikely to result in a sharp return of appetite the following day. The Patient Information Leaflet and your prescriber are the right sources for specific missed-dose guidance, none of this replaces that. For context on how the dose schedule works across the full titration, the Wegovy dosage plan page explains each step.

If you are thinking about stopping Wegovy, either briefly for surgery or permanently, the five-week clearance window is clinically significant. NHS England advises telling your anaesthetist and surgical team that you are taking a GLP-1 medicine before any procedure, because of the effects semaglutide has on gastric emptying. The medicine needs to have cleared sufficiently before certain general anaesthetics. Your surgical team will give you a specific stop date.

If you are planning a pregnancy or stopping contraception, the clearance window matters too: current guidance recommends ensuring the medicine has left your system before trying to conceive. That five-week estimate is the starting point, but your prescriber or GP should give you a personalised recommendation before you make any changes.

Where 1mg sits in the titration (and how that changes your clearance picture

The standard Wegovy titration begins at 0.25mg, moves to 0.5mg, then to 1mg, before continuing upward through 1.7mg and toward the 2.4mg maintenance dose) or the newer 7.2mg option for those where higher doses are clinically appropriate. The full range of Wegovy doses is worth reading if you want the broader context of where 1mg fits.

At 1mg you are typically around 12 weeks into treatment. Steady state (the point at which the amount of semaglutide entering your body each week roughly equals the amount being cleared) is reached after approximately four to five doses at any given level. So by the time most people are injecting 1mg weekly, they have already passed through a period where semaglutide was building up, and a period where it held steady.

Stopping at this point means the clearance curve runs in reverse: the body works through those five half-lives, and most people notice the return of appetite or reduced satiety before the medicine has fully gone. That subjective experience moves faster than the pharmacokinetic reality. If you are considering what happens after the final dose more broadly, the clearance timeline after your last dose covers that in more depth.

When to speak to a prescriber rather than work from a timeline

The five-week clearance estimate is a pharmacokinetic guide, not a clinical instruction. Individual factors (kidney function, BMI, other medicines you take) can all influence how semaglutide is metabolised. And some situations genuinely need a clinical view rather than a general figure.

Any planned pause, dose change, or switch to a different treatment should be reviewed by a prescriber before you act on it. If you are seeing Wegovy treatment for the first time and wondering about costs alongside the pharmacology, the Wegovy cost page explains how UK private prescribing is priced. For anyone thinking about starting or continuing weight management treatment through a regulated online pharmacy, checking eligibility with our prescribers is the straightforward next step, consultations are free, and a named prescriber reviews every case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions